6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazine-2-carboxylic acid, 98+%, 250mg

Ethyl 2-(2-aminoacetamido)acetate hydrochloride, 95.0%, 5g

1-(5-(Trifluoromethyl)pyridin-3-yl)ethanone, 97.0%, 250mg

Volumetric flasks with glass stopper, class A Clear glass, 50 ml, 12/21, 2 Piece(s)

4,6-Dichloro-2-hydrazino-1,3-benzothiazole, 95.0%, 1g

3-Cyclopropyl-1-ethyl-1H-pyrazol-5-amine, 95.0%, 100mg

4,4'-((4-Bromophenyl)azanediyl)dibenzaldehyde, 97.0%, 25g

2-(Trifluoromethyl)pyridine>95.0%(GC)1g

12-Bromododec-1-ene, 95.0%, 5g

2-Hydroxy-N-methylacetamide, 95.0%, 25g

3-Bromothiophene-2-carboxaldehyde, 98.0%, 10g

N'-(4-chloro-1,3-benzothiazol-2-yl)-N,N-dimethylethane-1,2-diamine, 95.0%, 250mg

(1S)-1-[6-(TRIFLUOROMETHYL)(3-PYRIDYL)]ETHYLAMINE, 95%, 250mg